Overview
Sharon Aharoni practices in Petah Tiqwa, Israel. Aharoni is rated as an Experienced expert by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. Their top areas of expertise are Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Spinal Muscular Atrophy Type 2, and Spinal Muscular Atrophy Type 3.
Their clinical research consists of co-authoring 36 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Chronic Inflammatory Demyelinating Polyneuropathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Myoclonic EpilepsyAharoni isAdvanced. Learn about Myoclonic Epilepsy.
- Primary Lateral SclerosisAharoni isAdvanced. Learn about Primary Lateral Sclerosis.
- Spinal Muscular Atrophy (SMA)
- Spinal Muscular Atrophy Type 2
- Spinal Muscular Atrophy Type 3
- Experienced
- Attention Deficit Hyperactivity Disorder (ADHD)
- Autosomal Recessive Cutis Laxa Type 1
- Becker Muscular DystrophyAharoni isExperienced. Learn about Becker Muscular Dystrophy.
- Charcot-Marie-Tooth DiseaseAharoni isExperienced. Learn about Charcot-Marie-Tooth Disease.
- Chronic Inflammatory Demyelinating Polyneuropathy
- Congenital Myasthenic SyndromeAharoni isExperienced. Learn about Congenital Myasthenic Syndrome.